Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA)
R Chin, Kevin Chen, Abul Usmani, et al.
Molecular Diagnosis & Therapy (2019) Vol. 23, Iss. 3, pp. 311-331
Open Access | Times Cited: 152

Showing 26-50 of 152 citing articles:

Updates on Clinical Use of Liquid Biopsy in Colorectal Cancer Screening, Diagnosis, Follow-Up, and Treatment Guidance
Omayma Mazouji, Abdelhak Ouhajjou, Roberto Incitti, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 43
Making the Rounds: Exploring the Role of Circulating Tumor DNA (ctDNA) in Non-Small Cell Lung Cancer
Misty Dawn Shields, Kevin Chen, Giselle Dutcher, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9006-9006
Open Access | Times Cited: 31
Framework for Adoption of Next-Generation Sequencing (NGS) Globally in the Oncology Area
Denis Horgan, Yosr Hamdi, Jonathan A. Lal, et al.
Healthcare (2023) Vol. 11, Iss. 3, pp. 431-431
Open Access | Times Cited: 20
Liquid biopsy for pediatric diffuse midline glioma: a review of circulating tumor DNA and cerebrospinal fluid tumor DNA
Tej D. Azad, Michael C. Jin, Lydia J. Bernhardt, et al.
Neurosurgical FOCUS (2020) Vol. 48, Iss. 1, pp. E9-E9
Open Access | Times Cited: 49
Dynamics of cell-free tumour DNA correlate with treatment response of head and neck cancer patients receiving radiochemotherapy
Franz J. Hilke, Francesc Muyas, Jakob Admard, et al.
Radiotherapy and Oncology (2020) Vol. 151, pp. 182-189
Open Access | Times Cited: 41
ctDNA MRD Detection and Personalized Oncogenomic Analysis in Oligometastatic Colorectal Cancer From Plasma and Urine
Bruna Pellini, Nadja Pejovic, Wenjia Feng, et al.
JCO Precision Oncology (2021), Iss. 5, pp. 378-388
Open Access | Times Cited: 38
Integrative analysis of multi-omics data for liquid biopsy
Geng Chen, Jing Zhang, Qiaoting Fu, et al.
British Journal of Cancer (2022) Vol. 128, Iss. 4, pp. 505-518
Open Access | Times Cited: 24
The Promise of Circulating Tumor DNA in Head and Neck Cancer
Sukhkaran S. Aulakh, Dustin A. Silverman, Kurtis Young, et al.
Cancers (2022) Vol. 14, Iss. 12, pp. 2968-2968
Open Access | Times Cited: 22
Circulating tumor DNA as liquid biopsy in lung cancer: Biological characteristics and clinical integration
Changshu Li, Jun Shao, Peiyi Li, et al.
Cancer Letters (2023) Vol. 577, pp. 216365-216365
Open Access | Times Cited: 14
Detecting liquid remnants of solid tumors treated with curative intent: Circulating tumor DNA as a biomarker of minimal residual disease (Review)
Huijuan Chen, Qiming Zhou
Oncology Reports (2023) Vol. 49, Iss. 5
Open Access | Times Cited: 13
Particle beam radiobiology status and challenges: a PTCOG Radiobiology Subcommittee report
Reem Ahmad, Amelia Barcellini, Kilian Baumann, et al.
International Journal of Particle Therapy (2024) Vol. 13, pp. 100626-100626
Open Access | Times Cited: 5
CRISPR/Cas13a-based supersensitive circulating tumor DNA assay for detecting EGFR mutations in plasma
L X Wang, Xiaosha Wen, Yang Yang, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 4
Bridging the gap: The role of technological advances in shaping gastrointestinal oncological outcomes
N. Rama, Inês Sousa
World Journal of Gastrointestinal Oncology (2025) Vol. 17, Iss. 3
Closed Access
The Method of Minimal Residual Disease Detection With Circulating Tumor DNA and Its Clinical Applications in Colorectal Cancer
Ming Liu, Tianhao Mu, Jia Gu, et al.
Cancer Reports (2025) Vol. 8, Iss. 3
Open Access
Beyond traditional biopsies: the emerging role of ctDNA and MRD on breast cancer diagnosis and treatment
Hussein Sabit, Mohamed S. Attia, Nouran Mohamed, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Neoadjuvant immune checkpoint therapy: Enabling insights into fundamental human immunology and clinical benefit
Kristen E. Pauken, Omar Alhalabi, Sangeeta Goswami, et al.
Cancer Cell (2025)
Closed Access
Commercial ctDNA Assays for Minimal Residual Disease Detection of Solid Tumors
Kevin Chen, Misty Dawn Shields, Pradeep S. Chauhan, et al.
Molecular Diagnosis & Therapy (2021) Vol. 25, Iss. 6, pp. 757-774
Open Access | Times Cited: 32
Oligometastatic Head and Neck Cancer: Challenges and Perspectives
Houda Bahig, Shao Hui Huang, Brian O’Sullivan
Cancers (2022) Vol. 14, Iss. 16, pp. 3894-3894
Open Access | Times Cited: 21
The Future of ctDNA-Defined Minimal Residual Disease: Personalizing Adjuvant Therapy in Colorectal Cancer
Alisha Bent, Shreya Raghavan, Arvind Dasari, et al.
Clinical Colorectal Cancer (2022) Vol. 21, Iss. 2, pp. 89-95
Open Access | Times Cited: 19
Circulating Exosome Cargoes Contain Functionally Diverse Cancer Biomarkers: From Biogenesis and Function to Purification and Potential Translational Utility
Megan I. Mitchell, Junfeng Ma, Claire L. Carter, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3350-3350
Open Access | Times Cited: 19
Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma
Srivandana Akshintala, R. Taylor Sundby, Donna Bernstein, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 17, pp. 3329-3339
Open Access | Times Cited: 11
Liquid Biopsy-Based Biosensors for MRD Detection and Treatment Monitoring in Non-Small Cell Lung Cancer (NSCLC)
Parvaneh Sardarabadi, Amir Asri Kojabad, Davod Jafari, et al.
Biosensors (2021) Vol. 11, Iss. 10, pp. 394-394
Open Access | Times Cited: 26
Circulating tumour DNA (ctDNA) in metastatic melanoma, a systematic review and meta-analysis
Lara Gracie, Yi Pan, Eshetu G. Atenafu, et al.
European Journal of Cancer (2021) Vol. 158, pp. 191-207
Open Access | Times Cited: 25
From Sampling to Sequencing: A Liquid Biopsy Pre-Analytic Workflow to Maximize Multi-Layer Genomic Information from a Single Tube
Kendra K. Maaß, Paulina Schad, Agnes M E Finster, et al.
Cancers (2021) Vol. 13, Iss. 12, pp. 3002-3002
Open Access | Times Cited: 23
Predictive and Prognostic Biomarkers for Lung Cancer Bone Metastasis and Their Therapeutic Value
Xupeng Chai, Eloy Yinwang, Zenan Wang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 23

Scroll to top